​Cough Syrup Down Syndrome, Clinical Treatment Study

Cough Syrup Down Syndrome
By: | Follow Twitter:
March 29, 2013
Also: BTD-001, Cough Syrup, Cough Syrup Down Syndrome, Down Syndrome, Monash University, Study

A cough syrup ingredient could be helpful in treating individuals with Down syndrome, according to researchers who are getting ready to conduct a clinical study.

Cough Syrup Down Syndrome

Researchers are getting ready to conduct a clinical study to determine if

They are working closely with Monash University in Australia to find out if the active ingredient helps these individuals with their cognitive abilities.

According to scientists, the study will focus on the ingredient known in the scientific community as BTD-001. Previously, this ingredient has been used in treating elderly patients with dementia.

“BTD-001 is a form of a drug product approved and used widely in many countries around the world from the 1920′s until the 1980′s to treat respiratory conditions and senile dementia (memory loss in the elderly),” according to a statement released by the Monash University.

CP Asia reports, Researchers are using this approach due to the fact that cognitive issues associated with senile dementia are very similar to those of Down syndrome, and BTD-001 could offer another treatment method to improving the cognitive functions for patients with Down syndrome.

During the study, scientists will be paying attention to how the ingredient is affecting their subject’s reaction time, memory, language skills, and overall behavior.

“In this clinical study, BTD-001 will be given at lower doses than those used in the past. Past use of higher doses was considered generally safe and well tolerated … the potential efficacy of BTD-001 in Down syndrome is supported by strong scientific evidence,” the press release read.